ŠUSTR, Filip and Miroslav SOUČEK. Rivaroxaban ve studii COMPASS (Rivaroxaban in COMPASS trial). Vnitřní lékařství. Solen, s. r. o., 2020, vol. 66, No 3, p. 197-198. ISSN 0042-773X. Available from: https://dx.doi.org/10.36290/vnl.2020.050. |
Other formats:
BibTeX
LaTeX
RIS
@article{1833559, author = {Šustr, Filip and Souček, Miroslav}, article_number = {3}, doi = {http://dx.doi.org/10.36290/vnl.2020.050}, keywords = {COMPASS, rivaroxaban, ASA, coronary artery disease}, issn = {0042-773X}, journal = {Vnitřní lékařství}, title = {Rivaroxaban ve studii COMPASS}, volume = {66}, year = {2020} }
TY - JOUR ID - 1833559 AU - Šustr, Filip - Souček, Miroslav PY - 2020 TI - Rivaroxaban ve studii COMPASS JF - Vnitřní lékařství VL - 66 IS - 3 SP - 197-198 EP - 197-198 PB - Solen, s. r. o. SN - 0042773X KW - COMPASS, rivaroxaban, ASA, coronary artery disease ER -
ŠUSTR, Filip and Miroslav SOUČEK. Rivaroxaban ve studii COMPASS (Rivaroxaban in COMPASS trial). \textit{Vnitřní lékařství}. Solen, s. r. o., 2020, vol.~66, No~3, p.~197-198. ISSN~0042-773X. Available from: https://dx.doi.org/10.36290/vnl.2020.050.
|